143 related articles for article (PubMed ID: 29123440)
41. Safety and tolerability of fluticasone furoate nasal spray once daily in paediatric patients aged 6-11 years with allergic rhinitis: subanalysis of three randomized, double-blind, placebo-controlled, multicentre studies.
Meltzer EO; Tripathy I; Máspero JF; Wu W; Philpot E
Clin Drug Investig; 2009; 29(2):79-86. PubMed ID: 19133703
[TBL] [Abstract][Full Text] [Related]
42. Increased gene expression of inflammatory markers in nasal turbinate of patients with persistent allergic rhinitis and chronic obstruction.
de Campos L; Galvão CES; Mairena EC; Voegels R; Kalil J; Castro FM; Cunha-Neto E
Eur Arch Otorhinolaryngol; 2019 Nov; 276(11):3247-3249. PubMed ID: 31363902
[TBL] [Abstract][Full Text] [Related]
43. IL-4 and TNF-alpha increased the secretion of eotaxin from cultured fibroblasts of nasal polyps with eosinophil infiltration.
Yoshifuku K; Matsune S; Ohori J; Sagara Y; Fukuiwa T; Kurono Y
Rhinology; 2007 Sep; 45(3):235-41. PubMed ID: 17956026
[TBL] [Abstract][Full Text] [Related]
44. [The role of chemokines in nasal polyps].
Caversaccio M; Hartnell A; Calnan D; Jose P; Mackay IS; Uguccioni M; Baggiolini M; Williams TJ; Conroy DM
Schweiz Med Wochenschr; 2000; Suppl 125():92S-95S. PubMed ID: 11141953
[TBL] [Abstract][Full Text] [Related]
45. Proton pump inhibitors decrease eotaxin-3/CCL26 expression in patients with chronic rhinosinusitis with nasal polyps: Possible role of the nongastric H,K-ATPase.
Min JY; Ocampo CJ; Stevens WW; Price CPE; Thompson CF; Homma T; Huang JH; Norton JE; Suh LA; Pothoven KL; Conley DB; Welch KC; Shintani-Smith S; Peters AT; Grammer LC; Harris KE; Hulse KE; Kato A; Modyanov NN; Kern RC; Schleimer RP; Tan BK
J Allergy Clin Immunol; 2017 Jan; 139(1):130-141.e11. PubMed ID: 27717558
[TBL] [Abstract][Full Text] [Related]
46. Measurement of inflammatory mediators of mast cells and eosinophils in native nasal lavage fluid in nasal polyposis.
Di Lorenzo G; Drago A; Esposito Pellitteri M; Candore G; Colombo A; Gervasi F; Pacor ML; Purello D'Ambrosio F; Caruso C
Int Arch Allergy Immunol; 2001 Jun; 125(2):164-75. PubMed ID: 11435734
[TBL] [Abstract][Full Text] [Related]
47. [The expression and significance of chemokines eotaxin and RANTES in the rat model of allergic rhinitis].
Tian C; Lei X; Shui M; Zhang Y; Jia Q; Tu J; Lian G; Tang S
Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2014 Jul; 28(14):1069-71. PubMed ID: 25330647
[TBL] [Abstract][Full Text] [Related]
48. Early phase resolution of mucosal eosinophilic inflammation in allergic rhinitis.
Uller L; Emanuelsson CA; Andersson M; Erjefält JS; Greiff L; Persson CG
Respir Res; 2010 May; 11(1):54. PubMed ID: 20459697
[TBL] [Abstract][Full Text] [Related]
49. Efficacy of the oral chemoattractant receptor homologous molecule on TH2 cells antagonist BI 671800 in patients with seasonal allergic rhinitis.
Krug N; Gupta A; Badorrek P; Koenen R; Mueller M; Pivovarova A; Hilbert J; Wetzel K; Hohlfeld JM; Wood C
J Allergy Clin Immunol; 2014 Feb; 133(2):414-9. PubMed ID: 24332218
[TBL] [Abstract][Full Text] [Related]
50. Steroid-sensitive indices of airway inflammation in children with seasonal allergic rhinitis.
Meyer P; Andersson M; Persson CG; Greiff L
Pediatr Allergy Immunol; 2003 Feb; 14(1):60-5. PubMed ID: 12603713
[TBL] [Abstract][Full Text] [Related]
51. [Effect of Acupoint Injection on Eosinophil Counts,Protein and mRNA Expressions of Eotaxin in Nasal Mucosa of Allergic Rhinitis Rats].
Zhang Y; Hou XR; Li LH; Yang M; Liang FH
Zhen Ci Yan Jiu; 2017 Apr; 42(2):141-4. PubMed ID: 29071962
[TBL] [Abstract][Full Text] [Related]
52. Comparison of the nasal release of IL-4, IL-10, IL-17, CCL13/MCP-4, and CCL26/eotaxin-3 in allergic rhinitis during season and after allergen challenge.
Baumann R; Rabaszowski M; Stenin I; Tilgner L; Scheckenbach K; Wiltfang J; Schipper J; Chaker A; Wagenmann M
Am J Rhinol Allergy; 2013; 27(4):266-72. PubMed ID: 23883806
[TBL] [Abstract][Full Text] [Related]
53. Effect of intranasal corticosteroid on pre-onset activation of eosinophils and mast cells in experimental Japanese cedar pollinosis.
Noyama Y; Okano M; Fujiwara T; Kariya S; Makihara S; Haruna T; Kanai K; Higaki T; Nishizaki K
Allergol Int; 2016 Jul; 65(3):259-65. PubMed ID: 26907728
[TBL] [Abstract][Full Text] [Related]
54. Effect of long-term, low-dose clarithromycin on T helper 2 cytokines, eosinophilic cationic protein and the 'regulated on activation, normal T cell expressed and secreted' chemokine in the nasal secretions of patients with nasal polyposis.
Perić A; Vojvodić D; Matković-Jožin S
J Laryngol Otol; 2012 May; 126(5):495-502. PubMed ID: 22559798
[TBL] [Abstract][Full Text] [Related]
55. Nasal cytology in patients with allergic rhinitis: effects of intranasal fluticasone propionate.
Meltzer EO; Orgel HA; Rogenes PR; Field EA
J Allergy Clin Immunol; 1994 Oct; 94(4):708-15. PubMed ID: 7930304
[TBL] [Abstract][Full Text] [Related]
56. Mediators and cytokines in persistent allergic rhinitis and nonallergic rhinitis with eosinophilia syndrome.
Gröger M; Klemens C; Wendt S; Becker S; Canis M; Havel M; Pfrogner E; Rasp G; Kramer MF
Int Arch Allergy Immunol; 2012; 159(2):171-8. PubMed ID: 22652688
[TBL] [Abstract][Full Text] [Related]
57. The effect of nasal polyp epithelial cells on eosinophil activation.
Shin SH; Lee SH; Jeong HS; Kita H
Laryngoscope; 2003 Aug; 113(8):1374-7. PubMed ID: 12897562
[TBL] [Abstract][Full Text] [Related]
58. Mucosal and systemic inflammatory changes in allergic rhinitis and asthma: a comparison between upper and lower airways.
Braunstahl GJ; Fokkens WJ; Overbeek SE; KleinJan A; Hoogsteden HC; Prins JB
Clin Exp Allergy; 2003 May; 33(5):579-87. PubMed ID: 12752585
[TBL] [Abstract][Full Text] [Related]
59. Differential Expression of Fas in Moderate/Severe and Mild Persistent Allergic Rhinitis and Its Correlation With Pathological Parameters.
Pirayesh A; Shahsavan S; Zargari Samani O; Shirzad H; Amani S; Zamani MA; Salimzadeh L; Bagheri N; Moghni M; Deris F
Am J Rhinol Allergy; 2019 May; 33(3):286-293. PubMed ID: 30648403
[TBL] [Abstract][Full Text] [Related]
60. Eosinophil markers in seasonal allergic rhinitis. Intranasal fluticasone propionate inhibits local and systemic increases during the pollen season.
Nielsen LP; Bjerke T; Christensen MB; Skamling M; Peterson CG; Mygind N; Dahl R
Allergy; 1998 Aug; 53(8):778-85. PubMed ID: 9722227
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
